Screening of Some Novel 4, 5 Disubstituted 1, 2, 4-Triazole-3-thiones for Anticonvulsant Activity

Author(s): Krishan K. Verma*, Umesh K. Singh, Jainendra Jain

Journal Name: Central Nervous System Agents in Medicinal Chemistry
Formerly Current Medicinal Chemistry - Central Nervous System Agents

Volume 20 , Issue 1 , 2020

Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Objective: In the present study, we synthesized fifteen 4, 5-disubstituted 1, 2, 4-triazol- 3-thione derivatives and evaluated for anticonvulsant activity with neurotoxicity determination.

Methods: The synthesized compounds were characterized using FTIR, 1H-NMR and MS. The molecular docking study was also performed to study the interactions of compounds with LYS329 residue of gamma amino butyric acid aminotransferase (GABA-AT) using Autodock 4.2 software. The anticonvulsant activity was assessed by maximal electroshock (MES) test and subcutaneous pentylenetetrazol (scPTZ) tests. The neurotoxicity was assessed by rotarod ataxia test.

Results: In MES test, compounds 5a, 8a and 9a were found active at 100 mg/kg and five compounds were found active at 300 mg/kg dose after 1 hr of administration. After 4 hr of drug administration, only two compounds 8a and 9a exhibited protection at 100 mg/kg. In scPTZ test, three compounds 2a, 6a and 8a were found active at 100 mg/kg and 7a was active at 300 mg/kg after 1 hr of test drug administration. Most of the compounds were found active in MES test with 8a and 9a being the most active among all. In docking study, 2a was found to be best compound based on the binding energy of -6.5 kcal/mol and estimated inhibition constant of 17.2 µM.

Conclusion: Majority of synthesized compounds were found active in MES test, whereas only few were found to possess anti scPTZ activity. Among all compounds, only 14a caused motor coordination impairment in rotarod ataxia test at 300 mg/kg 1 hr duration.

Keywords: Triazol-3-thiones, anticonvulsant activity, scPTZ, MES, docking, GABA-AT.

Ayala, G.F.; Dichter, M.; Gumnit, R.J.; Matsumoto, H.; Spencer, W.A. Genesis of epileptic interictal spikes. New knowledge of cortical feedback systems suggests a neurophysiological explanation of brief paroxysms. Brain Res., 1973, 52, 1-17.
[] [PMID: 4573428]
Bowman, J.F.; Edward, D.; Spitz, M. Encyclopedia of life sciences; Nature Publishing Group: Berlin, Germany, 2001. []
Perucca, E. The new generation of antiepileptic drugs: Advantages and disadvantages. Br. J. Clin. Pharmacol., 1996, 42(5), 531-543.
[] [PMID: 8951184]
Lin, Z.; Kadaba, P.K. Molecular targets for the rational design of antiepileptic drugs and related neuroprotective agents. Med. Res. Rev., 1997, 17(6), 537-572.
[PMID: 9359082]
Sinha, R.; Sara, U.V.S.; Khosa, R.L.; Stables, J.; Jain, J. Nicotinic acid hydrazones: A novel anticonvulsant pharmacophore. Med. Chem. Res., 2011, 20, 1499-1504.
Küçükgüzel, S.G.; Çıkla-Süzgün, P. Recent advances bioactive 1,2,4-triazole-3-thiones. Eur. J. Med. Chem., 2015, 97, 830-870.
[] [PMID: 25563511]
Plech, T.; Kaproń, B.; Luszczki, J.J.; Paneth, A.; Siwek, A.; Kołaczkowski, M.; Żołnierek, M.; Nowak, G. Studies on the anticonvulsant activity of 4-alkyl-1,2,4-triazole-3-thiones and their effect on GABAergic system. Eur. J. Med. Chem., 2014, 86, 690-699.
[] [PMID: 25226229]
Plech, T.; Luszczki, J.J.; Wujec, M.; Flieger, J.; Pizoń, M. Synthesis, characterization and preliminary anticonvulsant evaluation of some 4-alkyl-1,2,4-triazoles. Eur. J. Med. Chem., 2013, 60, 208-215.
[] [PMID: 23291122]
Yadav, M.K.; Tripathi, L.; Goswami, D. Synthesis and anticonvulsant activity (Chemo-Shock) of some Novel Schiff Bases of substituted 4-amino-5-phenyl-2, 4-dihydro-[1, 2, 4]-triazole-3-thione. Saudi J. Med. Pharm. Sci., 2017, 3(1), 45-54.
Siddiqui, N.; Alam, M.S.; Ahsan, W. Synthesis, anticonvulsant and toxicity evaluation of 2-(1H-indol-3-yl)acetyl-N-(substituted phenyl)hydrazine carbothioamides and their related heterocyclic derivatives. Acta Pharm., 2008, 58(4), 445-454.
[] [PMID: 19103578]
Verma, K.K.; Singh, U.K.; Jain, J. Design, synthesis and biological activity of some 4, 5-Disubstituted-2, 4- Dihydro-3H-1, 2, 4- Triazole-3-Thione derivatives. Cent. Nerv. Syst. Agents Med. Chem., 2019, 19(3), 197-205.
[] [PMID: 31749420]
Parmar, K.; Prajapati, S.; Patel, R. A simple and efficient procedure for synthesis of biologically active 1,2,4-Triazolo-[3,4-b]-1,3,4-thiadiazole -2-aryl-thiazolidine-4-one derivatives. Res. J. Chem. Sci., 2011, 1(1), 18-24.
Plech, T.; Kaproń, B.; Luszczki, J.J.; Wujec, M.; Paneth, A.; Siwek, A.; Kołaczkowski, M.; Zołnierek, M.; Nowak, G. Studies on the anticonvulsant activity and influence on GABA-ergic neurotransmission of 1,2,4-triazole-3-thione- based compounds. Molecules, 2014, 19(8), 11279-11299.
[] [PMID: 25090118]
Porter, R.J.; Cereghino, J.J.; Gladding, G.D.; Hessie, B.J.; Kupferberg, H.J.; Scoville, B.; White, B.G. Antiepileptic drug development program. Cleve. Clin. Q., 1984, 51(2), 293-305.
[] [PMID: 6380818]
Storici, P.; De Biase, D.; Bossa, F.; Bruno, S.; Mozzarelli, A.; Peneff, C.; Silverman, R.B.; Schirmer, T. Structures of gamma-aminobutyric acid (GABA) aminotransferase, a pyridoxal 5′-phosphate, and [2Fe-2S] cluster-containing enzyme, complexed with gamma-ethynyl-GABA and with the antiepilepsy drug vigabatrin. J. Biol. Chem., 2004, 279(1), 363-373.
[] [PMID: 14534310]

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2020
Published on: 03 March, 2020
Page: [41 - 48]
Pages: 8
DOI: 10.2174/1871524919666191209103003
Price: $65

Article Metrics

PDF: 16